Latest
-
Investing in pharmaceutical companies? The pipeline is key
A strong pipeline is all-important for pharmaceutical companies. We highlight the most interesting candidates.
-
DCC: a top-notch company going cheap
DCC has a stellar long-term record and promising prospects. It has been unfairly marked down
-
Three British small cap bargains to boost profitability
Three British small caps to invest in, according to Edward Wielechowski of the Odyssean Investment Trust
-
Share tips 2024: this week’s top picks
Share Tips Share tips 2024: MoneyWeek’s roundup of the top picks this week – here’s what the experts think you should buy
Share Tips -
Will platinum and palladium rise?
Analysis Platinum and palladium have lagged gold and silver recently, but the outlook is improving. Should you invest?
Analysis -
Top funds, stocks and trusts to invest in
We look at the top funds, stocks and trusts where investors have been putting their money over the past month. Are tech stocks out?
-
HSBC stocks jump – is its cost-cutting plan already paying off?
HSBC's reorganisation has left questions unanswered, but otherwise the banking sector is in robust health
-
James Halstead drives profits: should you buy?
James Halstead will rebound from a weak patch, while tax changes would be a buying opportunity
-
Invest in Babcock: an overlooked defence play
Defence stocks have outperformed this year, but Babcock has been left behind
